Get Started

RGEDF

PINK Chemical Works of Gedeon Richter Plc
Nov 9, 2026 · 3:17 PM ET DELAYED Market Open

$39.99 ↑ +0.48 (+1.22%) Trading Up from the previous close of $39.51, $0.22 below the day’s high of $40.21

YTD change
+3.34%
vs 20-day SMA
+1.22%
vs 200-day SMA
N/A

Price ranges

Previous day
$39.51 $39.72
open $39.72 close $39.51
-$0.22 (-0.55%)
Today
$39.99 $40.21
open $40.21 now $39.99
-$0.22 (-0.55%)
Past week
$38.75 $40.98
from $38.75 now $39.99
+$1.24 (+3.19%)
Past month
$35.75 $41.43
from $35.75 now $39.99
+$4.24 (+11.85%)
This year
$35.75 $45.28
from $38.69 now $39.99
+$1.29 (+3.34%)

Price & Performance

-3.09 (-7.27%) / 6M

$35.11$38.21$41.31$44.40May 11Aug 11Nov 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 11.7% away from all-time highs of $45.28
  • RGEDF is up 3% since the beginning of the year
  • RGEDF is up 3% over the past 12 months
  • RGEDF is up 12% over the past 1 month
  • 0% of all RGEDF investors are betting against RGEDF

RGEDF reads very good: the 12-month move is +35.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.6729
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 0.47

Balance sheet & scale

Income$655.8K
Revenue$2.8B
Cash$916.1M
Debt$61.7K
Income / Debt 10.63×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $7.3B

Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. The firm focuses on central nervous system, women's healthcare, cardiovascular, and OTC products. It operates through the following segments: Neuropsychiatry (CNS), General Medicines (GM), Women’s Healthcare (WHC), Biotechnology (BIO), and Pharma Other. The CNS segment focuses on building a pipeline of small molecule drug candidates mainly in the field of neuropsychiatry. The GM segment includes a traditional and generic portfolio in various therapeutic areas in the Central and Eastern European regions. The WHC segment provides pharmaceutical products for European women. The BIO segment is involved in its biotechnology platform to develop and manufacture biosimilar drugs for global markets. The Pharma Other segment relates to the remaining wholesale and retail business of the Group and all other activities. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,354.00 -0.79%
JNJ Johnson & Johnson $276.22 +1.43%
ABBV AbbVie, Inc. $291.31 +1.07%
MRK Merck & Co., Inc. $146.73 -0.14%
RHHBY Roche Holding Ltd Sponsored ADR $59.37 -0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.